J

Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223

Watchlist Manager
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Watchlist
Price: 35.87 CNY -1.05% Market Closed
Market Cap: 36B CNY
Have any thoughts about
Jiangsu Yuyue Medical Equipment & Supply Co Ltd?
Write Note

Jiangsu Yuyue Medical Equipment & Supply Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jiangsu Yuyue Medical Equipment & Supply Co Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash from Operating Activities
ÂĄ1.8B
CAGR 3-Years
9%
CAGR 5-Years
26%
CAGR 10-Years
28%
A
APT Medical Inc
SSE:688617
Cash from Operating Activities
ÂĄ689.1m
CAGR 3-Years
67%
CAGR 5-Years
106%
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash from Operating Activities
ÂĄ14.4B
CAGR 3-Years
17%
CAGR 5-Years
24%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Cash from Operating Activities
ÂĄ1.2B
CAGR 3-Years
2%
CAGR 5-Years
17%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Cash from Operating Activities
ÂĄ809.6m
CAGR 3-Years
-34%
CAGR 5-Years
-15%
CAGR 10-Years
11%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash from Operating Activities
ÂĄ132.5m
CAGR 3-Years
-66%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jiangsu Yuyue Medical Equipment & Supply Co Ltd
Glance View

Market Cap
35.8B CNY
Industry
Health Care

Jiangsu Yuyue Medical Equipment & Supply Co Ltd embodies the dynamic spirit of China's burgeoning healthcare sector. Founded in the heart of China's manufacturing hub, Jiangsu province, this company has steadily carved a niche for itself in the realm of medical equipment and supplies. With an eye for innovation and a sharp focus on quality, Yuyue specializes in the production of respiratory care devices, blood pressure monitors, and other medical diagnostics tools that are essential in both clinical settings and at-home healthcare. The company’s dedication to integrating advanced technology with user-friendly designs has not only propelled its domestic growth but also increased its footprint in international markets. By meticulously ensuring their products meet stringent regulatory standards, Yuyue competently aligns itself with the healthcare industry's rigorous demands. The financial lifeblood of Jiangsu Yuyue lies in its robust sales and distribution networks, which are critical in a sector as diversified and regulation-intensive as medical equipment. Through an extensive distribution network, including direct sales, strategic partnerships, and well-developed online platforms, the company effectively reaches both institutional clients and individual consumers. Additionally, the company leverages economies of scale and in-house expertise to maintain competitive pricing, helping it capture substantial market share. As healthcare needs continue to evolve globally, Yuyue's commitment to research and development positions it to not only meet current demands but also anticipate future trends, ensuring continuous revenue growth and reinforcing its status as a prominent player in the medical equipment industry.

Intrinsic Value
52.98 CNY
Undervaluation 32%
Intrinsic Value
Price
J

See Also

What is Jiangsu Yuyue Medical Equipment & Supply Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
1.8B CNY

Based on the financial report for Sep 30, 2024, Jiangsu Yuyue Medical Equipment & Supply Co Ltd's Cash from Operating Activities amounts to 1.8B CNY.

What is Jiangsu Yuyue Medical Equipment & Supply Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
28%

Over the last year, the Cash from Operating Activities growth was -39%. The average annual Cash from Operating Activities growth rates for Jiangsu Yuyue Medical Equipment & Supply Co Ltd have been 9% over the past three years , 26% over the past five years , and 28% over the past ten years .

Back to Top